SANGAMO THERAPEUTICS, INC.: cash_and_equivalents
| Value | {"amount": 114291000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} |
|---|---|
| Period | (as of 2019-09-30) |
| Status | current |
| Entity | SANGAMO THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T09:41:48.840967+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/977c3760-f464-473f-9651-eaa3297f3343
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001628280-19-013510Retrieved: 2026-08-19T09:41:48.840967+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001001233/cash-and-equivalents/2019-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/977c3760-f464-473f-9651-eaa3297f3343
History
- no predecessors — first report